Literature DB >> 20018613

Peroxiredoxin 1 stimulates secretion of proinflammatory cytokines by binding to TLR4.

Jonah R Riddell1, Xiang-Yang Wang, Hans Minderman, Sandra O Gollnick.   

Abstract

Peroxiredoxin 1 (Prx1) is an antioxidant and molecular chaperone that can be secreted from tumor cells. Prx1 is overexpressed in many cancers, and elevation of Prx1 is associated with poor clinical outcome. In the current study, we demonstrate that incubation of Prx1 with thioglycollate-elicited murine macrophages or immature bone marrow-derived dendritic cells resulted in TLR4-dependent secretion of TNF-alpha and IL-6 and dendritic cell maturation. Optimal secretion of cytokines in response to Prx1 was dependent upon serum and required CD14 and MD2. Binding of Prx1 to thioglycollate macrophages occurred within minutes and resulted in TLR4 endocytosis. Prx1 interaction with TLR4 was independent of its peroxidase activity and appeared to be dependent on its chaperone activity and ability to form decamers. Cytokine expression occurred via the TLR-MyD88 signaling pathway, which resulted in nuclear translocation and activation of NF-kappaB. These findings suggest that Prx1 may act as danger signal similar to other TLR4-binding chaperone molecules such as HSP72.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20018613      PMCID: PMC2955897          DOI: 10.4049/jimmunol.0901945

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology.

Authors:  Sarah C Higgins; Ed C Lavelle; Chantelle McCann; Brian Keogh; Edel McNeela; Patricia Byrne; Brian O'Gorman; Andrew Jarnicki; Peter McGuirk; Kingston H G Mills
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

2.  Hsp70 release from peripheral blood mononuclear cells.

Authors:  Claire Hunter-Lavin; Emma L Davies; Maria M F V G Bacelar; Michael J Marshall; Sarah M Andrew; John H H Williams
Journal:  Biochem Biophys Res Commun       Date:  2004-11-12       Impact factor: 3.575

3.  Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo.

Authors:  S O Gollnick; X Liu; B Owczarczak; D A Musser; B W Henderson
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

4.  Peroxiredoxin I expression in human thyroid tumors.

Authors:  T Yanagawa; T Ishikawa; T Ishii; K Tabuchi; S Iwasa; S Bannai; K Omura; H Suzuki; H Yoshida
Journal:  Cancer Lett       Date:  1999-10-18       Impact factor: 8.679

5.  Involvement of thioredoxin in rheumatoid arthritis: its costimulatory roles in the TNF-alpha-induced production of IL-6 and IL-8 from cultured synovial fibroblasts.

Authors:  S Yoshida; T Katoh; T Tetsuka; K Uno; N Matsui; T Okamoto
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

6.  Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.

Authors:  Jianjun Shen; Maria D Person; Jijiang Zhu; James L Abbruzzese; Donghui Li
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

7.  Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer.

Authors:  Jong Wook Chang; Seung Hee Lee; Ju Yeon Jeong; Ho Zoon Chae; Young Chul Kim; Zee-Yong Park; Yung Joon Yoo
Journal:  FEBS Lett       Date:  2005-05-23       Impact factor: 4.124

8.  Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein.

Authors:  Jong Sung Park; Daiva Svetkauskaite; Qianbin He; Jae-Yeol Kim; Derek Strassheim; Akitoshi Ishizaka; Edward Abraham
Journal:  J Biol Chem       Date:  2003-12-04       Impact factor: 5.157

9.  Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells.

Authors:  Brent Berwin; Justin P Hart; Stuart Rice; Cecilia Gass; Salvatore V Pizzo; Steven R Post; Christopher V Nicchitta
Journal:  EMBO J       Date:  2003-11-17       Impact factor: 11.598

10.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

Authors:  K Inaba; M Inaba; N Romani; H Aya; M Deguchi; S Ikehara; S Muramatsu; R M Steinman
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  72 in total

1.  Proteomic analysis of bronchoalveolar lavage fluid proteins from mice infected with Francisella tularensis ssp. novicida.

Authors:  Susan M Varnum; Bobbie-Jo M Webb-Robertson; Joel G Pounds; Ronald J Moore; Richard D Smith; Charles W Frevert; Shawn J Skerrett; David Wunschel
Journal:  J Proteome Res       Date:  2012-06-22       Impact factor: 4.466

2.  Surface layers of Clostridium difficile endospores.

Authors:  Patima Permpoonpattana; Elisabeth H Tolls; Ramez Nadem; Sisareuth Tan; Alain Brisson; Simon M Cutting
Journal:  J Bacteriol       Date:  2011-09-23       Impact factor: 3.490

3.  Selective photodepletion of malignant T cells in extracorporeal photopheresis with selenorhodamine photosensitizers.

Authors:  Zachariah A McIver; Mark W Kryman; Young Choi; Benjamin N Coe; Gregory A Schamerhorn; Michelle K Linder; Kellie S Davies; Jacqueline E Hill; Geri A Sawada; Jason M Grayson; Michael R Detty
Journal:  Bioorg Med Chem       Date:  2016-06-02       Impact factor: 3.641

4.  Quantitative Proteomic Analysis of Peripheral Blood Mononuclear Cells in Ankylosing Spondylitis by iTRAQ.

Authors:  Anji Cai; Suwen Qi; Zhuowa Su; Huaqing Shen; Yu Yang; Liang He; Yong Dai
Journal:  Clin Transl Sci       Date:  2015-03-19       Impact factor: 4.689

5.  miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potency.

Authors:  Yunjie Lu; Keli L Hippen; Amanda L Lemire; Jian Gu; Weizhi Wang; Xuhao Ni; Parvathi Ranganathan; Bruce L Levine; James L Riley; Carl H June; Laurence A Turka; David H Munn; Ramiro Garzon; Ling Lu; Bruce R Blazar
Journal:  Blood       Date:  2016-08-02       Impact factor: 22.113

6.  Peroxiredoxin 1 controls prostate cancer growth through Toll-like receptor 4-dependent regulation of tumor vasculature.

Authors:  Jonah R Riddell; Wiam Bshara; Michael T Moser; Joseph A Spernyak; Barbara A Foster; Sandra O Gollnick
Journal:  Cancer Res       Date:  2011-02-22       Impact factor: 12.701

7.  Sodium methyldithiocarbamate exerts broad inhibition of cellular signaling and expression of effector molecules of inflammation.

Authors:  Xiaomin Deng; Bindu Nanduri; Wei Tan; Bing Cheng; Ruping Fan; Stephen B Pruett
Journal:  Toxicol Sci       Date:  2013-09-20       Impact factor: 4.849

8.  Distinct characteristics of two 2-Cys peroxiredoxins of Vibrio vulnificus suggesting differential roles in detoxifying oxidative stress.

Authors:  Ye-Ji Bang; Man Hwan Oh; Sang Ho Choi
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

9.  Overexpression of peroxiredoxin-3 and -5 is a potential biomarker for prognosis in endometrial cancer.

Authors:  Jung Mi Byun; Su Sun Kim; Ki Tae Kim; Mi Seon Kang; Dae Hoon Jeong; Dae Sim Lee; Eun Jung Jung; Young Nam Kim; Jin Han; In Sung Song; Kyoun Bok Lee; Moon Su Sung
Journal:  Oncol Lett       Date:  2018-01-31       Impact factor: 2.967

10.  Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal.

Authors:  Sonia Salzano; Paola Checconi; Eva-Maria Hanschmann; Christopher Horst Lillig; Lucas D Bowler; Philippe Chan; David Vaudry; Manuela Mengozzi; Lucia Coppo; Sandra Sacre; Kondala R Atkuri; Bita Sahaf; Leonard A Herzenberg; Leonore A Herzenberg; Lisa Mullen; Pietro Ghezzi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.